Type a keyword or Post Title
'Feel good' brain messenger can be willfully controlled, new study reveals

in by Hospital + Health | Hospital Equipment and Medical Products Suppliers Directory 0 Reviews

From the thrill of hearing an ice cream truck approaching to the spikes of pleasure while sipping a fine wine, the neurological messenger known as dopamine has been popularly described as the brain's "feel good" chemical related to reward and pleasure. A ubiquitous neurotransmitter that carries signals between brain cells, dopamine...

Read More
Experimental drug shows potential against Alzheimer's disease

in by Hospital + Health | Hospital Equipment and Medical Products Suppliers Directory 0 Reviews

Researchers at Albert Einstein College of Medicine have designed an experimental drug that reversed key symptoms of Alzheimer's disease in mice. The drug works by reinvigorating a cellular cleaning mechanism that gets rid of unwanted proteins by digesting and recycling them. The study was published online today in the journal Cell. "Dis...

Read More
Brendan Murphy says CSL will reach a million COVID vaccines a week soon

in by Hospital + Health | Hospital Equipment and Medical Products Suppliers Directory 0 Reviews

The head of the Health Department has outlined some of the reasons why Australia's local production of the AstraZeneca vaccine has not hit its original goal of a million doses a week. Key points: CSL made around 830,000 doses of the AstraZeneca vaccine in the first week of local production Batch release and manufacturing work fl...

Read More
AstraZeneca COVID-19 vaccine doses have better efficacy when given 12 weeks apart, study finds

in by Hospital + Health | Hospital Equipment and Medical Products Suppliers Directory 0 Reviews

Waiting three months between the first and second dose of the AstraZeneca COVID-19 vaccine results in high efficacy, backing current recommendations from Australian authorities, new research shows. Key points: Australia's regulator recommends a 12-week gap between AstraZeneca doses Research in The Lancet shows the first of the two ja...

Read More
The first doses of the Oxford-AstraZeneca COVID vaccine have arrived. What happens next?

in by Hospital + Health | Hospital Equipment and Medical Products Suppliers Directory 0 Reviews

Australia has doubled its coronavirus vaccine stocks after hundreds of thousands of doses of the Oxford-AstraZeneca vaccine were flown into Sydney on Sunday. The federal government says it hopes the new vaccine will be going into people's arms from Monday, March 8. What happened on Sunday? Three hundred thousand doses of the Oxford-Ast...

Read More
'Gamechanger' drug for treating obesity cuts body weight by 20 percent

in by Hospital + Health | Hospital Equipment and Medical Products Suppliers Directory 0 Reviews

One third (35%) of people who took a new drug for treating obesity lost more than one-fifth (greater than or equal to 20%) of their total body weight, according to a major global study involving UCL researchers. The findings from the large-scale international trial, published today in the New England Journal for Medicine, are being hailed as a...

Read More
Inside CSL, where Australia's Oxford-AstraZeneca vaccines are being made

in by Hospital + Health | Hospital Equipment and Medical Products Suppliers Directory 0 Reviews

At the back of a building in Melbourne's northern outskirts is a long, narrow room roughly the area of a tennis court. Technicians and operators — fully decked out in protective onesies, gloves, goggles, hairnets and masks — bustle about, tending to a vast array of gleaming stainless steel equipment and what looks like kilometres...

Read More
Could mass testing for COVID-19 prevent Australia's next coronavirus lockdown?

in by Hospital + Health | Hospital Equipment and Medical Products Suppliers Directory 0 Reviews

Austria, Slovakia and Luxembourg have done it. China shut down an entire city to do it as well. Mass testing of an entire population to detect both symptomatic and non-symptomatic coronavirus infections has also been trialled by some cities in the United Kingdom. There is a school of thought that conducting such large-scale health screenin...

Read More
China’s Inactivated COVID-19 vaccine candidate is safe and provokes immune response, say preliminary clinical trial results

in by Hospital + Health | Hospital Equipment and Medical Products Suppliers Directory 0 Reviews

A new study published in The Lancet on Thursday found that an inactivated vaccine candidate, called BBIBP-CorV, was safe and provoked an immune response in healthy individuals. This is the first study of an inactivated COVID-19 vaccine to include participants over 60 years of age. The BBIBP-CorV vaccine is being developed by the Beijing Ins...

Read More
Inflammatory Bowel Disease

in by Hospital + Health | Hospital Equipment and Medical Products Suppliers Directory 0 Reviews

A change in diet is part of treating inflammatory bowel diseases like Crohn’s disease and ulcerative colitis. Now researchers have tracked specific changes in the gut microbiome and the metabolic products they produce as being a likely important part of remission. Inflammatory bowel disease (IBD) are chronic inflammatory conditions of gast...

Read More